Skip to main content Scroll Top

alzheimer

Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
JIN
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Alzheimer Articles scientifiques
29 mai 2024
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
JIN
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Alzheimer Articles scientifiques
11 mars 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Alzheimer Communications orales
24 octobre 2023
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Challenges in developing Geroscience trials
Nature-communications
Challenges in developing Geroscience trials
Alzheimer Articles scientifiques
19 août 2023
Challenges in developing Geroscience trials
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
CTAD-2023
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Alzheimer Communications affichées
1 décembre 2022
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
JAD_journal-of-Alzheimer..
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Alzheimer Articles scientifiques
1 novembre 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer Communications orales
16 septembre 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer Communications orales
2 janvier 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
Relevance of photobiomodulation technique in AD treatment
Relevance of photobiomodulation technique in AD treatment
Alzheimer Communications orales
5 novembre 2020
Relevance of photobiomodulation technique in AD treatment
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
Alzheimer Communications affichées
1 décembre 2019
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
Alzheimer Communications affichées
30 novembre 2019
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Alzheimer Communications affichées
1 octobre 2019
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
1 2